ENANTA PHARMACEUTICALS INC Annual Nonoperating Income (Expense) in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Enanta Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to 2024.
  • Enanta Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $668K, a 55.8% decline year-over-year.
  • Enanta Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $3.9M, a 37.2% decline year-over-year.
  • Enanta Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2024 was $3.9M, a 37.2% decline from 2023.
  • Enanta Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2023 was $6.21M, a 275% increase from 2022.
  • Enanta Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was $1.66M, a 17% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.9M -$2.31M -37.2% Oct 1, 2023 Sep 30, 2024 10-K 2024-11-27
2023 $6.21M +$4.56M +275% Oct 1, 2022 Sep 30, 2023 10-K 2024-11-27
2022 $1.66M -$338K -17% Oct 1, 2021 Sep 30, 2022 10-K 2024-11-27
2021 $1.99M -$4.63M -69.9% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-22
2020 $6.62M -$2.2M -24.9% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-23
2019 $8.82M +$4.03M +84% Oct 1, 2018 Sep 30, 2019 10-K 2021-11-24
2018 $4.79M +$2.46M +105% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-25
2017 $2.33M +$614K +35.7% Oct 1, 2016 Sep 30, 2017 10-K 2019-11-27
2016 $1.72M +$412K +31.5% Oct 1, 2015 Sep 30, 2016 10-K 2018-11-29
2015 $1.31M +$1.02M +362% Oct 1, 2014 Sep 30, 2015 10-K 2017-12-11
2014 $283K -$315K -52.7% Oct 1, 2013 Sep 30, 2014 10-K 2016-12-09
2013 $598K +$488K +444% Oct 1, 2012 Sep 30, 2013 10-K 2015-12-11
2012 $110K +$2.1M Oct 1, 2011 Sep 30, 2012 10-K 2014-12-11
2011 -$1.99M Oct 1, 2010 Sep 30, 2011 10-K 2013-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.